These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 30431407)

  • 21. Measuring effectiveness of needle and syringe exchange programmes for prevention of HIV among injecting drug users.
    Amundsen EJ
    Addiction; 2006 Jul; 101(7):911-2. PubMed ID: 16771880
    [No Abstract]   [Full Text] [Related]  

  • 22. Can outreach work?
    Morrison CL; Ruben SM
    Addiction; 1995 Oct; 90(10):1401-4. PubMed ID: 8616469
    [No Abstract]   [Full Text] [Related]  

  • 23. Secondary syringe exchange as a model for HIV prevention programs in the Russian Federation.
    Irwin K; Karchevsky E; Heimer R; Badrieva L
    Subst Use Misuse; 2006; 41(6-7):979-99. PubMed ID: 16809182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Syringe exchange programs in Brazil: preliminary assessment of 45 programs.
    Fonseca EM; Ribeiro JM; Bertoni N; Bastos FI
    Cad Saude Publica; 2006 Apr; 22(4):761-70. PubMed ID: 16612430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How to run a successful needle exchange program.
    AIDS Alert; 1997 Nov; 12(11):129-31. PubMed ID: 11364772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of Service Providers of Needle Syringe Program in Preventing HIV/AIDS.
    Tsai TI; Morisky DE; Chen YM
    AIDS Educ Prev; 2010 Dec; 22(6):546-57. PubMed ID: 21204630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Feasibility of needle and syringe programs in Tajikistan distributing low dead space needles.
    Zule WA; Latypov A; Otiashvili D; Bangel S; Bobashev GV
    Harm Reduct J; 2018 Aug; 15(1):44. PubMed ID: 30170604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reducing HIV infection among new injecting drug users in the China-Vietnam Cross Border Project.
    Des Jarlais DC; Kling R; Hammett TM; Ngu D; Liu W; Chen Y; Binh KT; Friedmann P
    AIDS; 2007 Dec; 21 Suppl 8():S109-14. PubMed ID: 18172378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Significance of Harm Reduction as a Social and Health Care Intervention for Injecting Drug Users: An Exploratory Study of a Needle Exchange Program in Fresno, California.
    Clarke K; Harris D; Zweifler JA; Lasher M; Mortimer RB; Hughes S
    Soc Work Public Health; 2016; 31(5):398-407. PubMed ID: 27167664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Qualitative evaluation of a peer-based needle syringe programme in Vietnam.
    Ngo AD; Schmich L; Higgs P; Fischer A
    Int J Drug Policy; 2009 Mar; 20(2):179-82. PubMed ID: 18242971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seroprevalence of HCV and HIV infection among clients of the nation's longest-standing statewide syringe exchange program: A cross-sectional study of Community Health Outreach Work to Prevent AIDS (CHOW).
    Salek TP; Katz AR; Lenze SM; Lusk HM; Li D; Des Jarlais DC
    Int J Drug Policy; 2017 Oct; 48():34-43. PubMed ID: 28779632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a needle social marketing strategy to control HIV among injecting drug users in China.
    Wu Z; Luo W; Sullivan SG; Rou K; Lin P; Liu W; Ming Z
    AIDS; 2007 Dec; 21 Suppl 8():S115-22. PubMed ID: 18172379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Syringe and needle exchange as HIV/AIDS prevention for injection drug users in Puerto Rico.
    Robles RR; Colón HM; Matos TD; Finlinson HA; Muñoz A; Marrero CA; García M; Reyes JC
    Health Policy; 1998 Sep; 45(3):209-20. PubMed ID: 10338952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing syringe exchange programs.
    Des Jarlais DC; Braine N
    Addiction; 2004 Sep; 99(9):1081-2. PubMed ID: 15317623
    [No Abstract]   [Full Text] [Related]  

  • 35. Syringe exchange as a social movement: a case study of harm reduction in Oakland, California.
    Bluthenthal RN
    Subst Use Misuse; 1998 Apr; 33(5):1147-71. PubMed ID: 9596381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of combination approach on harm reduction programs: the Taiwan experience.
    Lin T; Chen CH; Chou P
    Harm Reduct J; 2016 Jul; 13(1):23. PubMed ID: 27377896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advocacy and coverage of needle exchange programs: results of a comparative study of harm reduction programs in Brazil, Bangladesh, Belarus, Ukraine, Russian Federation, and China.
    Burrows D
    Cad Saude Publica; 2006 Apr; 22(4):871-9. PubMed ID: 16612440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Syringe access for injection drug users in Rhode Island.
    Boutwell A; Rich JD
    Med Health R I; 2004 Jan; 87(1):15-6. PubMed ID: 14989076
    [No Abstract]   [Full Text] [Related]  

  • 39. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Syringe and needle exchange as HIV/AIDS prevention for injection drug users.
    Watters JK; Estilo MJ; Clark GL; Lorvick J
    JAMA; 1994 Jan; 271(2):115-20. PubMed ID: 8264065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.